logo
AI Icon𝛼SK or Search
ENTITY

Molbio Diagnostics Limited (1788863D IN)

8
Analysis
Health Care • India
Molbio Diagnostics Limited is looking to raise about US$229m in its upcoming India IPO. The deal will be run by Kotak, IIFL, Jefferies and Motilal. Molbio Diagnostics is a healthcare technology company specializing in point-of-care molecular diagnostics. Its flagship product, the Truenat platform, is a portable, battery-operated PCR testing system used for the rapid detection of infectious and some non-communicable diseases. The company sells two main types of products: (1) hardware devices such as the Trueprep sample preparation unit and the Truelab PCR analyzers and (2) consumable test kits tailored to detect specific diseases. Truenat’s menu spans testing for more than 30 diseases, including tuberculosis, COVID-19, HIV, hepatitis B and C, HPV, malaria, and other infectious conditions. As of FY25, Molbio has deployed over 10,000 devices across more than 80 countries, though its revenue base remains primarily domestic, with ~80% of revenue from India and the remaining 20% from international markets such as Nigeria, Bangladesh, and Indonesia. The company operates five manufacturing facilities in India.
more
bearish•Molbio Diagnostics Limited
•10 Aug 2026 19:48

Molbio IPO Review: Point Of Care Medtech - Recovering from Post-COVID Blues

​Molbio's Trunat platform offers WHO-approved portable molecular diagnostics for 30 diseases, with revenue growth despite post-COVID dip and...

Logo
Himanshu Dugar
111 Views
Share
bullish•Molbio Diagnostics Limited
•09 Aug 2026 13:05

Primer: Molbio Diagnostics Limited (1788863D IN) - Aug 2026

Molbio Diagnostics is a leading player in the point-of-care (POC) molecular diagnostics market, primarily in India, with its WHO-endorsed...

Logo
αSK Primers
103 Views
Share
bearish•Molbio Diagnostics Limited
•07 Aug 2026 22:02

Molbio Diagnostics Limited (1788863D IN): Synthetic Expert Call Transcript (07 Aug 2026)

Transitioning remote healthcare clinics to molecular diagnostics is bottlenecked by fragmented clinical protocols and major payment delays rather...

Logo
Share
bullish•Molbio Diagnostics Limited
•07 Aug 2026 08:30

Molbio Diagnostics IPO: Attractive Business Model; Profitable Operations; Reasonable Valuation

Molbio Diagnostics will launch its India IPO on August 10 to fund capex. IPO price band is set at INR768–807.  Subscription will close on August...

Logo
Tina Banerjee
144 Views
Share
bullish•Molbio Diagnostics Limited
•23 Oct 2025 10:30

Molbio Diagnostics Limited Pre-IPO: Steady Growths in Topline And Profitability

​Molbio Diagnostics Limited plans to raise $229m in India IPO, known for point-of-care molecular diagnostics with Truenat PCR testing system.

Logo
Hong Jie Seow
488 Views
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x